NCT06821945View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Schizophrenia
Interventions
DRUG

BR5402A

Subjects take the investigational products once a day

DRUG

BR5402A-1

Subjects take the investigational products once a day

DRUG

BR5402B

Subjects take the investigational products once a day

DRUG

BR5402B-1

Subjects take the investigational products once a day

DRUG

BR5402C

Subjects take the investigational products once a day

DRUG

BR5402C-1

Subjects take the investigational products once a day

DRUG

BR5402D

Subjects take the investigational products once a day

DRUG

BR5402D-1

Subjects take the investigational products once a day

Trial Locations (2)

Unknown

RECRUITING

Kyungbook National university hospital, Daegu

NOT_YET_RECRUITING

Hanyang University Guri Hospital, Guri-si

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY